Meeder Asset Management Inc Repligen Corp Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Meeder Asset Management Inc holds 29 shares of RGEN stock, worth $4,249. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 35 17.14%

Holding current value

$4,249

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$119.79 - $167.35 $718 - $1,004	-6 Reduced 17.14%	29 $4,000
Q2 2024 Aug 08, 2024	BUY	$120.0 - $182.95 $1,200 - $1,829	10 Added 40.0%	35 $4,000
Q1 2024 May 07, 2024	BUY	$170.78 - $208.42 $4,269 - $5,210	25 New	25 $4,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $13,956 - $22,290	87 Added 25.59%	427 $80,000
Q2 2022 Aug 08, 2022	BUY	$140.68 - $188.02 $7,596 - $10,153	54 Added 18.88%	340 $55,000
Q1 2022 May 10, 2022	BUY	$161.19 - $257.96 $46,100 - $73,776	286 New	286 $54,000
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $34,910 - $42,930	-141 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$194.77 - $324.21 $389 - $648	-2 Reduced 1.4%	141 $41,000
Q2 2021 Aug 09, 2021	BUY	$165.87 - $220.95 $4,312 - $5,744	26 Added 22.22%	143 $29,000
Q1 2021 Apr 28, 2021	BUY	$180.37 - $226.26 $9,559 - $11,991	53 Added 82.81%	117 $23,000
Q4 2020 Feb 09, 2021	BUY	$148.08 - $206.57 $3,553 - $4,957	24 Added 60.0%	64 $12,000
Q3 2020 Nov 02, 2020	BUY	$122.51 - $158.27 $1,470 - $1,899	12 Added 42.86%	40 $6,000
Q2 2020 Aug 11, 2020	BUY	$94.33 - $140.48 $1,320 - $1,966	14 Added 100.0%	28 $3,000
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $11,299 - $14,515	-133 Reduced 90.48%	14 $1,000
Q4 2019 Feb 13, 2020	SELL	$73.84 - $93.08 $436,320 - $550,009	-5,909 Reduced 97.57%	147 $13,000
Q3 2019 Oct 17, 2019	BUY	$76.65 - $95.51 $115,281 - $143,647	1,504 Added 33.04%	6,056 $464,000
Q2 2019 Aug 05, 2019	SELL	$54.2 - $85.95 $74,308 - $117,837	-1,371 Reduced 23.15%	4,552 $390,000
Q1 2019 Apr 16, 2019	BUY	$49.45 - $62.8 $64,680 - $82,142	1,308 Added 28.34%	5,923 $350,000
Q4 2018 Jan 17, 2019	BUY	$48.26 - $68.88 $207,711 - $296,459	4,304 Added 1383.92%	4,615 $244,000
Q3 2018 Nov 02, 2018	BUY	$46.8 - $58.97 $8,236 - $10,378	176 Added 130.37%	311 $0
Q2 2018 Jul 24, 2018	BUY	$35.26 - $47.04 $4,760 - $6,350	135 New	135 $0
Q1 2018 May 03, 2018	SELL	$30.92 - $37.27 $12,955 - $15,616	-419 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$32.53 - $38.92 $45,346 - $54,254	-1,394 Reduced 76.89%	419 $15,000
Q3 2017 Oct 20, 2017	BUY	$36.98 - $46.06 $67,044 - $83,506	1,813	1,813 $69,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.13B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Repligen Corp Transaction History